News
Reassuring data on long-term outcomes among kids with MIS-C
August 31, 2021
Most children who develop multisystemic inflammatory syndrome after infection with SARS-CoV-2 recover relatively quickly and without significant sequelae.
News
Long COVID symptoms can persist for more than 1 year, study shows
August 31, 2021
The largest study to date confirms that a substantial number of COVID-19 survivors have persistent problems. One researcher calls it a “modern medical challenge of the first order.”
News
CDC panel unanimously backs Pfizer vax, fortifying FDA approval
August 30, 2021
The risk of myocarditis after a COVID infection was 6 to 34 times higher than the risk after receiving an mRNA vaccine.
News
Children’s upper airways primed to combat SARS-CoV-2 infection
August 30, 2021
The findings may help to explain why children have a lower risk of developing severe COVID-19 illness or becoming infected with SARS-CoV-2 in the first place.
News
U.S. plans COVID-19 booster shots at 6 months instead of 8: WSJ
August 27, 2021
Approval of boosters for three COVID-19 shots being administered in the United States is expected in mid-September.
News
Genetic link may tie cannabis use disorder to severe COVID-19
August 27, 2021
“These data have important implications for policy regarding vaccination as well as treatment prioritization,” said lead author Dr. Alexander S. Hatoum.
News
One-third in U.S. had been infected by SARS-CoV-2 through 2020: Study
August 26, 2021
“We have not turned the corner on COVID-19 and are nowhere near herd immunity – if it exists for SARS-CoV-2.”
News
Children and COVID: New cases soar to near-record level
August 24, 2021
Vaccine initiations were down for the second consecutive week, but COVID-related deaths showed a big increase.
News
Health care workers eager for COVID booster shots
August 23, 2021
Almost all of the health care workers surveyed – 98% of physicians and 94% of nurses/APNs – have been fully vaccinated against COVID-19.
News
FDA fully approves Pfizer COVID-19 vaccine
August 23, 2021
It is the first COVID-19 vaccine to be fully licensed in the United States. It will be marketed under the trade name Comirnaty.